Cell and Gene Therapy Market Size, Share, Trends, Industry Outlook and Forecast 2023-2028

IMARC Group, a leading market research company, has recently releases report titled “Cell and Gene Therapy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028,”  The study provides a detailed analysis of the industry, including the global cell and gene therapy market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

What is Cell and Gene Therapy?

Cell and gene therapy refers to the usage of cells and genetic material to treat and cure diseases. These therapies aim to modify the genetic material of cells to correct or replace genes that are missing or defective. They are rapidly advancing the field of medicine. In cell therapy, cells are harvested from a patient or a donor and then manipulated and expanded in a laboratory before being infused back into the patient. This approach is extensive used to treat diseases, such as cancer and autoimmune disorders. In gene therapy, genetic material is introduced into cells to replace missing or defective genes, which is done through a variety of methods, including viral vectors and CRISPR-Cas9 gene editing technology.

Request for a free sample copy of this report: https://www.imarcgroup.com/cell-gene-therapy-market/requestsample

What are the growth prospects and trends in the cell and gene industry?

The increasing prevalence of chronic diseases, such as cancer, diabetes, and cardiovascular disorders, represents a significant factor driving the market growth across the globe. In line with this, favorable policies from regulatory agencies for the development and approval of new therapies is contributing to the growth of the market. Other factors, such as the increasing research and development (R&D) activities and the rising demand for innovative therapies, are creating a positive outlook for the market further across the globe.

What is included in market segmentation?

The report has segmented the market into the following categories:

Breakup by therapy type:

• Cell Therapy
  • Stem Cell
    • Pluripotent Stem Cell
    • Cancer Stem Cell
    • Adult Stem Cell
  • Non-Stem Cell
    • T Cells
    • Natural Killer
    • Others
• Gene Therapy

Breakup by Indication:

• Cardiovascular Disease
• Oncology Disorder
• Genetic Disorder
• Infectious Disease
• Neurological Disorder
• Others

Breakup by Delivery Mode:

• In-Vivo
• Ex-Vivo

Breakup by End User:

• Hospitals
• Cancer Care Centers
• Pharmaceutical & Biotechnology Companies
• Others

Market Breakup by Region:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

Who are the key players operating in the industry?

The report covers the major market players including:

• Amgen Inc.
• Biogen
• Bluebird bio, Inc.
• Bristol-Myers Squibb
• Gilead Science
• Kolon TissueGene Inc.
• Orchard Therapeutics plc.
• Pfizer Inc
• Renova Therapeutics
• Spark Therapeutics, Inc

Ask Analyst for Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/cell-gene-therapy-market

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact US:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Email: sales@imarcgroup.com

Follow us on Twitter: @imarcglobal

LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/

Article source: https://article-realm.com/article/Business/44782-Cell-and-Gene-Therapy-Market-Size-Share-Trends-Industry-Outlook-and-Forecast-2023-2028.html